00000nam 2200000zi 4500 9.944698 CaOODSP 20241031111735 m o d f cr mn||||||||| 241030t20242024onc ob f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- H113-28/2024-8E-PDF Natamycin and its associated end-use products : final decision. Ottawa, Ontario : Pest Management Regulatory Agency, Health Canada, 2024. ©2024 1 online resource (10 pages). text txt rdacontent computer c rdamedia online resource cr rdacarrier Re-evaluation decision, 1925-1025 ; RVD2024-08 Cover title. Issued also in French under title: Natamycine et préparations commerciales connexes : décision finale. "24 October 2024." Includes bibliographical references. "This document presents the final re-evaluation decision for the re-evaluation of natamycin, including the response to comments received, and the required label updates. All products containing natamycin regulated under the Pest Control Products Act in Canada are subject to this re-evaluation decision"--Page 1. Antifungal agents Certification Canada. Antifungal agents Risk assessment Canada. Antifungal agents Risk mitigation Canada. Canada. Pest Management Regulatory Agency, issuing body. Natamycine et préparations commerciales connexes : (CaOODSP)9.944719 Re-evaluation decision (Canada. Pest Management Regulatory Agency) RVD2024-08. (CaOODSP)9.505209 PDF 254 KB https://publications.gc.ca/collections/collection_2024/sc-hc/h113-28/H113-28-2024-8-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/consumer-product-safety/reports-publications/pesticides-pest-management/decisions-updates/reevaluation-decision/2024/natamycin.html